SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000318154-20-000012
Filing Date
2020-01-30
Accepted
2020-01-30 16:13:31
Documents
16
Period of Report
2020-01-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K amgn-20191231form8xk.htm   iXBRL 8-K 62066
2 EX-99.1 amgn-20191231xq4ex991.htm EX-99.1 967976
8 GRAPHIC amgenlogoa14.jpg GRAPHIC 6206
  Complete submission text file 0000318154-20-000012.txt   1291176

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amgn-20200130.xsd EX-101.SCH 5324
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amgn-20200130_cal.xml EX-101.CAL 638
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amgn-20200130_def.xml EX-101.DEF 17999
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amgn-20200130_lab.xml EX-101.LAB 38962
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amgn-20200130_pre.xml EX-101.PRE 19607
13 EXTRACTED XBRL INSTANCE DOCUMENT amgn-20191231form8xk_htm.xml XML 8565
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37702 | Film No.: 20561526
SIC: 2836 Biological Products, (No Diagnostic Substances)